Prescriptions
The question
To ask the Secretary of State for Health and Social Care, whether he has had discussions with the Medicines and Healthcare products Regulatory Agency on reducing overprescribing.
Answered by Karin Smyth
I have discussed with the Medicines and Healthcare products Regulatory Agency (MHRA) concerns raised by Members of Parliament about the adverse effects of antidepressant prescribing, and what the MHRA can do to improve communication on the risks of different medicines.
Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →